| 1 |
32256946 | Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients. | 2020 |
1 |
| 2 |
32827712 | PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease. | 2020 Oct 15 |
3 |
| 3 |
32967340 | Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease. | 2020 Sep 21 |
7 |
| 4 |
28441923 | Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life. | 2019 Jun |
1 |
| 5 |
29782204 | Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans. | 2018 May 21 |
3 |
| 6 |
30178714 | Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer. | 2018 Sep |
3 |
| 7 |
27671515 | Processes of plasma protein N-homocysteinylation in multiple sclerosis. | 2017 Aug |
2 |
| 8 |
26825875 | Involvement of homocysteine, homocysteine thiolactone, and paraoxonase type 1 (PON-1) in the etiology of defective human sperm function. | 2016 Mar |
1 |
| 9 |
29215249 | [The role of lipoprotein-associated enzyme paraoxonase 1 and its polymorphisms in the pathogenesis of endothelial dysfunction and somatic complications in patients with alcoholism: Review ]. | 2016 Jan-Mar |
1 |
| 10 |
25245648 | Serum lipids, tHcy, hs-CRP, MDA and PON-1 levels in SCH and overt hypothyroidism: effect of treatment. | 2014 Aug 20 |
1 |
| 11 |
25386429 | Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur. | 2014 Sep |
1 |
| 12 |
24314997 | Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients. | 2013 |
1 |
| 13 |
22643843 | Paraoxonase 1 and homocysteine metabolism. | 2012 Oct |
5 |
| 14 |
22673025 | The growing importance of PON1 in cardiovascular health: a review. | 2012 Jul |
2 |
| 15 |
19419786 | Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia. | 2010 Nov 5 |
4 |
| 16 |
20012900 | Is alcohol beneficial or harmful for cardioprotection? | 2010 Jun |
1 |
| 17 |
19155603 | Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration. | 2009 Jan |
3 |
| 18 |
19219535 | Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease. | 2009 May |
1 |
| 19 |
19454176 | Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia. | 2009 |
2 |
| 20 |
19597297 | Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients. | 2009 |
2 |
| 21 |
18084236 | Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients. | 2008 Jul |
1 |
| 22 |
18781288 | Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes. | 2008 Sep |
2 |
| 23 |
17971175 | Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice. | 2007 Dec |
1 |
| 24 |
16958606 | Lipid peroxidation and homocysteine levels in Behçet's disease. | 2006 |
3 |
| 25 |
16106241 | Protein homocysteinylation: a new mechanism of atherogenesis? | 2005 |
2 |
| 26 |
12601623 | Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity. | 2003 Feb |
1 |